DOUBLE MEDICAL TECHNOLOGY INC. Financials Double Medical Technology Inc.
Equities
002901
CNE1000032W7
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.89 CNY | -1.37% |
|
-4.66% | -23.90% |
Valuation
| Fiscal Period: December | 2018 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 11,839 | 20,310 | 14,062 | 12,789 | 12,789 | - |
| Enterprise Value (EV) 1 | 11,839 | 20,310 | 14,062 | 16,805 | 12,789 | 12,789 |
| P/E ratio | 31.8 x | 30.3 x | 155 x | 290 x | 44.8 x | 31.2 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 15.3 x | 10.2 x | - | 11 x | 6.35 x | 4.92 x |
| EV / Revenue | 15.3 x | 10.2 x | - | 11 x | 6.35 x | 4.92 x |
| EV / EBITDA | - | 22.6 x | - | 58.4 x | 23.2 x | 17.2 x |
| EV / FCF | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - |
| Price to Book | 8.26 x | 8.08 x | - | 5.49 x | 3.95 x | 3.65 x |
| Nbr of stocks (in thousands) | 400,100 | 401,232 | 413,232 | 414,020 | 414,020 | - |
| Reference price 2 | 29.59 | 50.62 | 34.03 | 30.89 | 30.89 | 30.89 |
| Announcement Date | 1/30/19 | 3/29/22 | 4/28/23 | 3/29/24 | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net sales 1 | 772.5 | 1,994 | - | 1,533 | 2,014 | 2,599 |
| EBITDA 1 | - | 897.8 | - | 287.5 | 552 | 743 |
| EBIT 1 | 440.8 | 822 | - | 103.2 | 496 | 712 |
| Operating Margin | 57.06% | 41.22% | - | 6.73% | 24.63% | 27.4% |
| Earnings before Tax (EBT) 1 | 440.7 | 802.5 | - | 99.74 | 489 | 708 |
| Net income 1 | 371.5 | 673.3 | - | 58.97 | 284 | 411 |
| Net margin | 48.09% | 33.76% | - | 3.85% | 14.1% | 15.81% |
| EPS 2 | 0.9300 | 1.670 | 0.2200 | 0.1400 | 0.6900 | 0.9900 |
| Free Cash Flow | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 1/30/19 | 3/29/22 | 4/28/23 | 3/29/24 | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2024 Q1 |
|---|---|
| Net sales 1 | 469 |
| EBITDA | - |
| EBIT | - |
| Operating Margin | - |
| Earnings before Tax (EBT) | - |
| Net income 1 | 75 |
| Net margin | 15.99% |
| EPS | - |
| Dividend per Share | - |
| Announcement Date | - |
1CNY in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2021 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - |
| Net Cash position | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - |
| ROE (net income / shareholders' equity) | 28.1% | 26.7% | 1.95% | 8.8% | 11.7% |
| ROA (Net income/ Total Assets) | - | - | 4.4% | 5.4% | 6.2% |
| Assets 1 | - | - | 4,159 | 5,259 | 6,629 |
| Book Value Per Share 2 | 3.580 | 6.260 | 7.390 | 7.820 | 8.470 |
| Cash Flow per Share | 0.8300 | 1.670 | - | - | - |
| Capex 1 | - | - | 304 | 400 | 350 |
| Capex / Sales | - | - | 19.84% | 19.86% | 13.47% |
| Announcement Date | 1/30/19 | 3/29/22 | 3/29/24 | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
30.89
CNY
Average target price
41
CNY
Spread / Average Target
+32.73%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -23.90% | 1.77B | |
| +11.57% | 127B | |
| -5.05% | 11.32B | |
| +3.22% | 9.04B | |
| +38.90% | 5.56B | |
| -21.83% | 4.72B | |
| +8.74% | 3.45B | |
| -6.82% | 2.86B | |
| -13.32% | 2.04B | |
| -6.99% | 2.07B |
- Stock Market
- Equities
- 002901 Stock
- Financials Double Medical Technology Inc.
